Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial

Autor: Cella, David, Grünwald, Viktor, Nathan, Paul, Doan, Justin, Dastani, Homa, Taylor, Fiona, Bennett, Bryan, DeRosa, Michael, Berry, Scott, Broglio, Kristine, Berghorn, Elmer, Motzer, Robert J
Zdroj: In The Lancet Oncology July 2016 17(7):994-1003
Databáze: ScienceDirect